Outcome of 841 Older Patients (> 55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols

Goekbuget N, Viardot A, Steffen B, Hahn J, Spriewald B, Martin S, Raffel S, Teichmann LL, Trummer A, Alsdorf W, Morgner A, Schwartz S, Stelljes M, Vucinic V, Alakel N, Stoltefuss A, Baldus CD, Brueggemann M, Serve H, Hoelzer D (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Conference Proceedings Title: BLOOD

Event location: New Orleans, LA

DOI: 10.1182/blood-2022-158934

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Goekbuget, N., Viardot, A., Steffen, B., Hahn, J., Spriewald, B., Martin, S.,... Hoelzer, D. (2022). Outcome of 841 Older Patients (> 55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols. In BLOOD. New Orleans, LA: WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Goekbuget, Nicola, et al. "Outcome of 841 Older Patients (> 55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols." Proceedings of the 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA WASHINGTON: AMER SOC HEMATOLOGY, 2022.

BibTeX: Download